🔎 Trials Near Me

Home › Melanoma › California › Mountain View

Melanoma clinical trials in Mountain View, CA

12 studies for Melanoma are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

RecruitingPhase 1
  • Stanford Cancer Institute, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150664

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

RecruitingPhase 1/2
  • Stanford Cancer Institute (Melanoma/NSCLC), Stanford · 5 mi away
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06060613

Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis

RecruitingPhase 3
  • Stanford University (Data Collection Only), Stanford · 5 mi away
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT07890415

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi away
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

RecruitingPhase 2
  • Stanford University, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06712927

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

RecruitingPhase 1/2
  • Stanford Cancer Institute, Stanford · 5 mi away
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

RecruitingPhase 3
  • Stanford Comprehensive Cancer Center, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

RecruitingPhase 2/3
  • Stanford, Stanford · 5 mi away
Ages 18 and older · All sexes · Updated Apr 22, 2026 · NCT06624644

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

RecruitingPhase 2/3
  • Stanford Cancer Institute, Palo Alto · 5 mi away
All ages · All sexes · Updated Apr 2, 2026 · NCT06581406

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

RecruitingPhase 1
  • Stanford Cancer Institute, Stanford · 5 mi away
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Stanford · 5 mi away
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
  • Stanford Cancer Institute, Palo Alto · 5 mi away
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

About Melanoma

Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.

More about Melanoma on MedlinePlus

Melanoma trials in other cities

Other studies in Mountain View

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.